| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q4 2024 | 1 | 0 | 13F-HR | 2/14/2025 | 000121390025014355 | |
| Q3 2024 | 68 | 2,037,780 | RVMD, TYRA, NUVL, ONC | 13F-HR | 11/14/2024 | 000089534524000585 |
| Q2 2024 | 61 | 1,898,904 | RVMD, SWTX, CYTK, MRUS | 13F-HR | 8/14/2024 | 000089534524000355 |
| Q1 2024 | 59 | 2,024,741 | SWTX, CYTK, RVMD, TYRA | 13F-HR | 5/15/2024 | 000089534524000182 |
| Q4 2023 | 52 | 2,006,361 | MRTX, CYTK, SWTX, RVMD | 13F-HR | 2/14/2024 | 000089534524000061 |
| Q3 2023 | 73 | 1,878,507 | MRTX, RVMD, ONC, TYRA | 13F-HR | 11/14/2023 | 000089534523000631 |
| Q2 2023 | 79 | 2,156,238 | RETA, APLS, RVMD, TYRA | 13F-HR | 8/14/2023 | 000089534523000469 |
| Q1 2023 | 75 | 2,035,630 | RXDX, RETA, ONC, SRPT | 13F-HR | 5/15/2023 | 000089534523000296 |
| Q4 2022 | 71 | 1,896,920 | RXDX, ONC, CYTK, RVMD | 13F-HR | 2/14/2023 | 000089534523000135 |
| Q3 2022 | 73 | 1,778,081 | MRTX, CYTK, RXDX, SWTX | 13F-HR | 11/14/2022 | 000095012322012323 |
| Q2 2022 | 76 | 1,578,912 | MRTX, CYTK, ONC, RVMD | 13F-HR | 8/15/2022 | 000095012322009489 |
| Q1 2022 | 74 | 1,945,613 | MRTX, SWTX, ITOS, ONC | 13F-HR | 5/16/2022 | 000095012322006483 |
| Q4 2021 | 71 | 2,574,770 | MRTX, XBI, ITOS, ONC | 13F-HR | 2/14/2022 | 000095012322003002 |
| Q3 2021 | 88 | 2,863,585 | MRTX, ONC, SWTX, ITOS | 13F-HR | 11/15/2021 | 000095012321015597 |
| Q2 2021 | 95 | 2,834,340 | MRTX, ONC, SWTX, ITOS | 13F-HR | 8/16/2021 | 000095012321011427 |
| Q1 2021 | 85 | 2,948,612 | MRTX, ONC, RVMD, SWTX | 13F-HR | 5/17/2021 | 000095012321007061 |
| Q4 2020 | 78 | 3,110,957 | MRTX, ONC, SWTX, ITOS | 13F-HR | 2/16/2021 | 000095012321002862 |
| Q3 2020 | 75 | 2,893,710 | IMMU, ONC, MRTX, RVMD | RESTATEMENT | 11/17/2020 | 000095012320012232 |
| Q2 2020 | 65 | 2,274,579 | IMMU, MRTX, ONC, ODTC | 13F-HR | 8/14/2020 | 000095012320009123 |
| Q1 2020 | 62 | 1,467,229 | MRTX, IMMU, ONC, ODTC | 13F-HR | 5/15/2020 | 000095012320005395 |
| Q4 2019 | 51 | 1,768,107 | MRTX, IMMU, ONC, ODTC | 13F-HR | 2/14/2020 | 000095012320002532 |
| Q3 2019 | 49 | 1,379,234 | ONCE, MRTX, ONC, IMMU | 13F-HR | 11/14/2019 | 000095012319011467 |
| Q2 2019 | 2 | 19,952 | ESPERION THERAPEUTICS INC NE calls, IMMUNOMEDICS INC calls | NEW HOLDINGS | 8/15/2019 | 000095012319008514 |
| Q2 2019 | 35 | 1,143,236 | MRTX, ODTC, ONC, IMMU | 13F-HR | 8/14/2019 | 000095012319008398 |
| Q1 2019 | 23 | 864,736 | MRTX, ONC, IMMU, ODTC | 13F-HR | 5/15/2019 | 000095012319005411 |
| Q4 2018 | 24 | 809,378 | ONC, SLDB, PTCT, WVE | 13F-HR | 2/14/2019 | 000095012319002250 |
| Q3 2018 | 24 | 901,189 | SLDB, ONC, PTCT, WVE | 13F-HR | 11/14/2018 | 000095012318011923 |
| Q2 2018 | 26 | 883,149 | SLDB, ONC, MRTX, PTCT | 13F-HR | 8/14/2018 | 000095012318008984 |
| Q1 2018 | 33 | 936,874 | AVXS, ONC, PTCT, ESPR | 13F-HR | 5/15/2018 | 000095012318005733 |
| Q4 2017 | 26 | 547,127 | AVXS, ODTC, ONC, ESPR | 13F-HR | 2/14/2018 | 000095012318002428 |
| Q3 2017 | 30 | 439,265 | AVXS, ONC, CLVSQ, MGNX | 13F-HR | 11/14/2017 | 000095012317010901 |
| Q2 2017 | 27 | 420,502 | AVXS, CLVSQ, ESPR, MDCO | 13F-HR | 8/14/2017 | 000095012317008000 |
| Q1 2017 | 31 | 457,649 | AVXS, CLVSQ, MDCO, ESPR | 13F-HR | 5/15/2017 | 000095012317005338 |
| Q4 2016 | 28 | 258,527 | AVXS, CLVSQ, MDCO, ONC | 13F-HR | 2/14/2017 | 000095012317002487 |
| Q3 2016 | 28 | 223,116 | CLVSQ, MDCO, BPMC, MEDICINES COMPANY calls | 13F-HR | 11/14/2016 | 000095012316022431 |
| Q2 2016 | 23 | 112,781 | ONC, BPMC, SGEN, INCY | 13F-HR | 8/15/2016 | 000095012316020185 |
| Q1 2016 | 22 | 102,188 | MRTX, BPMC, ONC, CPXX | 13F-HR | 5/16/2016 | 000095012316017634 |
| Q4 2015 | 15 | 115,826 | MRTX, AQXP, BPMC, SGEN | 13F-HR | 2/16/2016 | 000095012316015087 |